(Q38203777)

30 August 2017

1 reference

title

The influence of cytoreductive surgery on progression-free interval and survival in epithelial ovarian cancer (English)

1 reference

30 August 2017

1 reference

Hoskins WJ

1

1 reference

30 August 2017

1 March 1989

1 reference

Bailliere's clinical obstetrics and gynaecology

30 August 2017

1 reference

30 August 2017

3

1 reference

30 August 2017

59-71

1 reference

30 August 2017

1

1 reference

The second-look surgical reassessment for epithelial ovarian carcinoma.

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Debulking surgery: Does it increase the quality of survival?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Pelvic lymphadenectomy in operative treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

A review of second-look laparotomy for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Role of "third-look" laparotomy in the guidance of ovarian cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Second-look laparotomy for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Second-look laparotomy in managing epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Malignant tumors of the ovary managed with postoperative megavoltage irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Stage III epithelial ovarian cancer: the role of maximal surgical reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Current concepts in cancer: ovary--treatment for stages III and IV. The multimodal approach to the treatment of stage III ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

The changing prognosis and treatment in cancer of the ovary. A report of 235 patients with primary ovarian carcinoma 1952-1961

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Radiation therapy in the treatment of carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Analysis of sites of persistent cancer at "second-look" laparotomy in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Second-look operations in the planned management of advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Prognostic factors in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Cancer statistics, 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Second-look laparotomy after chemotherapy in the management of ovarian malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Rewiew of ovarian cancer at the University of Texas Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Second-look operation in ovarian carcinoma: postchemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Second-look laparotomy in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

The role of cytoreductive surgery in advanced carcinoma of the ovary: an analysis of primary and second surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Lymph node metastasis of ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2889%2980042-2

7 January 2021

10.1016/S0950-3552(89)80042-2

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

2472244